Tag Archives: Code authorisation

Published comment on MJA Insight: Vital transparency

http://www.mjainsight.com.au/view?post=ken-harvey-vital-transparency&post_id=11651&cat=comment FULL disclosure of the relationship between therapeutic goods companies, doctors and other stakeholders is currently in the hands of the Australian Competition and Consumer Commission. The ACCC is currently deciding if it will give the go-ahead to the 17th … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

Petition to ACCC on Medicines Australia Code Authorisation

While collaborations between industry and health professionals are desirable, widespread financial ties bring significant risks of undue influence on professional judgements, potentially jeopardizing the integrity of medical research, education, clinical practice and public trust in medicine, according to a landmark … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , | Leave a comment

ACCC now posting submissions on Medicines Australia Code

See: http://www.accc.gov.au/content/index.phtml/itemId/1063694/fromItemId/278039/display/submission The AMA’s submission to the ACCC is also available at:  http://ama.com.au/print/8101 “The AMA therefore commends Medicines Australia’s proposal to work further with stakeholders on the issue of public reporting on pharmaceutical companies interactions with individual healthcare professionals”. Reminiscent … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , | Leave a comment